| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9988789 | Clinical Neurology and Neurosurgery | 2018 | 4 Pages |
Abstract
If individuals with CADASIL present with immune mediated inflammatory components they may benefit from immunomodulatory therapy. This is discussed with a review of the inflammatory CADASIL/MS cases in the literature and report of a case.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
N. Schiess, K. Huether, M. Szolics, G. Agarwal, A.W. El-Hattab, S. Sathe,